1-2 of 2
Anne-Laure Cazeau
Close
Sort by
Journal Articles

Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90 y-Epratuzumab Tetraxetan Following R-CHOP in Elderly DLBCL Patients: A Lysa Phase II Prospective Trial

Françoise Kraeber-Bodere, MD, PhD, Amandine Pallardy, MD, Steven Le Gouill, Hervé Maisonneuve, MD, Thierry Lamy, MD, Krimo Bouabdallah, MD, Noel Milpied, MD, Henry Jardel, MD, Eric Deconinck, MD, PhD, Nadine Morineau, MD, Charles Foussard, MD, Annie Brion, MD, Remy Gressin, MD, Olivier Tournilhac, MD, PhD, Emmanuel Gyan, MD, PhD, Anne Moreau, MD, Christian Berthou, MD, Francois Dreyfus, Caroline Bodet-Milin, MD, Anne-Laure Cazeau, MD, Etienne Garin, MD, PhD, Jean-Philippe Vuillez, MD, PhD, Loic Campion, MD, Philippe Moreau, MD, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD, Pierre Soubeyran, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 906.
https://doi.org/10.1182/blood.V120.21.906.906
Published: 2012
Journal Articles

Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90Y Epratuzumab Tetraxetan Following R-CHOP In Elderly DLBCL Patients

Françoise kraeber-Bodere, Hervé Maisonneuve, MD, Thierry Lamy, Steven Le Gouill, Eric Deconninck, MD, Amandine Pallardy, Caroline bodet-Milin, Noel Milpied, MD, Nadine Morineau, MD, Charles Foussard, MD, Thomas Gastinne, Remy Gressin, MD, Olivier Tournilhac, MD, PhD, Emmanuel Gyan, MD, PhD, Anne Moreau, Alain Faivre-Chauvet, Anne-Laure Cazeau, Etienne Garin, Jean-Philippe Vuillez, Jean-François Chatal, Jean-Luc Harousseau, Philippe Moreau, William Wegener, MD, PhD, David Goldenberg, Pierre Soubeyran, MD
Journal: Blood
Blood (2010) 116 (21): 2875.
https://doi.org/10.1182/blood.V116.21.2875.2875
Published: 2010